Impact of hormonal biomarkers on response to hormonal therapy in advanced and recurrent endometrial cancer

American Journal of Obstetrics and Gynecology(2021)

引用 9|浏览4
暂无评分
摘要
Prediction of response to hormonal treatment in endometrial cancer improves substantially with a 50% cut-off level for PR-IHC and by applying a sequential test algorithm using PR-IHC and ER pathway activity scores. Results need to be validated in the PROMOTE-prospective study.
更多
查看译文
关键词
aromatase inhibitors,estrogen receptor pathway activity,progesterone receptor,progestin therapy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要